How is Myotonic Dystrophy Type 1 Inherited?
At a Glance
Myotonic dystrophy type 1 (DM1) has a 50% chance of being passed to a child. Symptoms often worsen in future generations due to genetic anticipation. Mothers passing the gene face a higher risk of having a child with severe congenital DM1, making genetic counseling vital before pregnancy.
In this answer
3 sections
If you or your partner have myotonic dystrophy type 1 (DM1), one of the most pressing questions is whether you will pass the condition to your children, and if so, how it will affect them.
Myotonic dystrophy type 1 is an autosomal dominant genetic condition [1]. This means that a person only needs one copy of the altered gene to develop the disease. If one parent has DM1, there is a 50% chance with each pregnancy that their child will inherit the gene and develop the condition, and a 50% chance they will not [1]. These odds are the same for every pregnancy, regardless of whether the child is a boy or a girl.
Genetic Anticipation: Why Symptoms Often Worsen in Future Generations
A common pattern in families with DM1 is that the disease tends to start at an earlier age and cause more severe symptoms in each successive generation [2][3]. In the medical world, this phenomenon is called genetic anticipation [2].
To understand why this happens, it helps to look at the specific gene involved. DM1 is caused by an alteration in the DMPK gene [4]. Within this gene, there is a sequence of DNA “letters” (C, T, and G) that repeats over and over [4][1].
- In people without the DM1 gene, this CTG sequence repeats fewer than 35 times.
- Intermediate/Premutation (35-49 repeats): People with this number of repeats typically do not develop DM1 symptoms themselves, but there is a risk that the sequence could expand into the disease-causing range when passed to their children [4][5].
- In people with DM1, this sequence repeats anywhere from 50 times to several thousand times [6][7].
These repeats are unstable. When the gene is passed from parent to child, the number of CTG repeats often increases, or “expands” [2][3]. Because there is a direct link between the length of the repeat expansion and the severity of the disease, a child who inherits a longer repeat sequence is likely to experience earlier and more severe symptoms than their parent [6][8].
The Maternal Bias and Congenital DM1
The risk of the repeat expanding heavily depends on which parent passes down the gene.
When a father passes the DM1 gene to his child, the repeat sequence usually still expands—leading to some worsening of symptoms—but the increase is generally smaller, and very rarely causes the most severe congenital forms [2][3]. On rare occasions, the repeat length may even shrink [3].
However, when a mother passes the DM1 gene to her child, there is a much higher risk of the repeat sequence expanding dramatically during the formation of her egg cells [2][9]. This significant jump in repeat size, often called a maternal bias, means that mothers with DM1 are much more likely to have a child with the most severe form of the disease, known as congenital myotonic dystrophy (CDM1) [10][2][11].
Congenital DM1 is present at birth and can cause severe muscle weakness, breathing difficulties, and developmental delays [12][2]. Even mothers who only have mild symptoms of DM1 can have a child with congenital DM1 if the repeat expansion increases drastically [8].
Family Planning and Genetic Counseling
Because the severity of DM1 can change so unpredictably from generation to generation, reproductive decision-making can be deeply stressful [13][14].
If you have DM1 and are considering having children, it is highly recommended to meet with a genetic counselor [15][14]. They can help you understand your specific risks and discuss your family planning options. Advanced technologies, such as preimplantation genetic testing (PGT), can be used during in vitro fertilization (IVF) to test embryos for the DM1 mutation before pregnancy [13][14].
For those who are already pregnant, prenatal testing is an option to determine if the baby has inherited the expanded gene. These include chorionic villus sampling (CVS) and amniocentesis, which test cells from the placenta or amniotic fluid [4][16].
Important Note on Maternal Health: Beyond the genetic risks to the child, pregnancy itself can pose physical risks to a mother with DM1. The physiological changes of pregnancy can increase the chance of complications such as cardiac issues or excessive amniotic fluid, making it vital to assemble a care team that includes a high-risk obstetrician [17][18].
Common questions in this guide
What are the chances of passing myotonic dystrophy type 1 to my child?
What does genetic anticipation mean in myotonic dystrophy?
Why is the risk of severe DM1 higher if the mother has the condition?
Can myotonic dystrophy be prevented in future pregnancies?
Questions for Your Doctor
5 questions
- •What is my specific CTG repeat number, and how does it impact the risk of expansion in my children?
- •Can you refer me to a genetic counselor who specializes in neuromuscular diseases to discuss family planning options like PGT?
- •If I choose to become pregnant, what high-risk obstetricians or maternal-fetal medicine specialists in our area have experience with myotonic dystrophy?
- •Are preimplantation genetic testing (PGT) and IVF typically covered by my insurance for this condition, or are there financial assistance programs?
- •Based on my symptoms and repeat count, what is the estimated risk of having a child with congenital myotonic dystrophy?
Questions for You
4 questions
- •Have I been formally genetically tested to know my exact CTG repeat count, or was my diagnosis based only on symptoms and family history?
- •If I have biological children already, have they shown any early signs of DM1, such as learning difficulties or early muscle weakness?
- •How do my partner and I feel about exploring assisted reproductive technologies like IVF with genetic testing?
- •What kind of support system do I have in place if I were to have a child with significant medical needs at birth?
Related questions
References
References (18)
- 1
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.
Raaijmakers RHL, Ripken L, Ausems CRM, Wansink DG
International journal of molecular sciences 2019; (20(15)) doi:10.3390/ijms20153689.
PMID: 31357652 - 2
Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.
Han JY, Jang W, Park J
Genes 2022; (13(8)) doi:10.3390/genes13081465.
PMID: 36011377 - 3
Unusual association of a unique CAG interruption in 5' of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism.
Tomé S, Dandelot E, Dogan C, et al.
Human mutation 2018; (39(7)):970-982 doi:10.1002/humu.23531.
PMID: 29664219 - 4
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
Sharp L, Cox DC, Cooper TA
Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.
PMID: 31509256 - 5
Myotonic dystrophy type 2: the 2020 update.
Meola G
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.
PMID: 33458578 - 6
Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
Chong-Nguyen C, Wahbi K, Algalarrondo V, et al.
Circulation. Cardiovascular genetics 2017; (10(3)) doi:10.1161/CIRCGENETICS.116.001526.
PMID: 28611030 - 7
Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats.
van der Plas E, Hamilton MJ, Miller JN, et al.
Journal of neuromuscular diseases 2019; (6(3)):321-332 doi:10.3233/JND-190397.
PMID: 31306140 - 8
Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
Stokes M, Varughese N, Iannaccone S, Castro D
Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.
PMID: 31520483 - 9
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Thomas JD, Sznajder ŁJ, Bardhi O, et al.
Genes & development 2017; (31(11)):1122-1133 doi:10.1101/gad.300590.117.
PMID: 28698297 - 10
[Beyond premature apnea pauses: congenital myotonic dystrophy type 1].
Del Olmo Segura P, Solé Delgado C, Martínez Del Val E
Andes pediatrica : revista Chilena de pediatria 2024; (95(5)):608-612 doi:10.32641/andespediatr.v95i5.5092.
PMID: 39760631 - 11
Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.
Yee C, Choi SJ, Oh SY, et al.
Obstetrics & gynecology science 2017; (60(4)):323-328 doi:10.5468/ogs.2017.60.4.323.
PMID: 28791262 - 12
The Study of the Inheritance Mechanisms of Myotonic Dystrophy Type 1 (DM1) in Families from the Republic of North Ossetia-Alania.
Ionova SA, Murtazina AF, Marakhonov AA, et al.
International journal of molecular sciences 2024; (25(17)) doi:10.3390/ijms25179734.
PMID: 39273681 - 13
Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
Best AF, Hilbert JE, Wood L, et al.
European journal of neurology 2019; (26(1)):58-65 doi:10.1111/ene.13763.
PMID: 30051542 - 14
Single-Tube Dodecaplex PCR Panel of Polymorphic Microsatellite Markers Closely Linked to the DMPK CTG Repeat for Preimplantation Genetic Diagnosis of Myotonic Dystrophy Type 1.
Lian M, Zhao M, Lee CG, Chong SS
Clinical chemistry 2017; (63(6)):1127-1140 doi:10.1373/clinchem.2017.271528.
PMID: 28428361 - 15
A Greek National Cross-Sectional Study on Myotonic Dystrophies.
Papadimas GK, Papadopoulos C, Kekou K, et al.
International journal of molecular sciences 2022; (23(24)) doi:10.3390/ijms232415507.
PMID: 36555146 - 16
Myotonic Dystrophy Type 1 Clinical, Electrophysiological and Molecular Characterization: Experience at Tertiary Care Centre.
Khadilkar S, Jagiasi K, Yadav J, et al.
The Journal of the Association of Physicians of India 2017; (65(6)):32-37.
PMID: 28782311 - 17
Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1.
Besant G, Bourque PR, Smith IC, et al.
Frontiers in cardiovascular medicine 2022; (9()):899606 doi:10.3389/fcvm.2022.899606.
PMID: 35722118 - 18
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al.
Neurologia 2020; (35(3)):185-206 doi:10.1016/j.nrl.2019.01.001.
PMID: 31003788
This page provides educational information about myotonic dystrophy type 1 inheritance and genetics. It does not replace professional medical advice from a genetic counselor, maternal-fetal medicine specialist, or neurologist.
Get notified when new evidence is published on Steinert myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.